drugset / Trial / NCT01299805

Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults

NCT01299805

Phase 1 Completed 17 enrolled Takeda
RandomizedParallel-groupSingle-blind

Summary

The purpose of this study is to evaluate the pharmacodynamics (the drug's effect on the body), the pharmacokinetics (the body's handling of the drug), and the safety and tolerability of vortioxetine, once daily (QD) in healthy men.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 20 mg Oral

Indications

No indication recorded.